ERBB2 and breast carcinoma: The resulting increase in SCD1 protein levels elevates saturated and mono-unsaturated fatty acid levels in the cell which incorporated into phospholipids, thereby elucidating the complex regulation of lipid metabolism and signaling pathways in HER2-positive breast cancer.